This is a resubmission of the first competitive renewal of a T32 training grant at the Maryland Psychiatric Research Center (MPRC), originally funded in 2003 (MH067533). The goal of the proposed program is to prepare MDs, PhDs and PharmDs interested in basic or clinical research for a career in translational research in schizophrenia. The MPRC, a division of the University Of Maryland Medical School Department Of Psychiatry, is a focused center for schizophrenia research, located on the grounds of the Spring Grove Hospital Center, an inpatient mental health hospital located just outside Baltimore. The faculty of the MPRC have an integrated research program of clinical and neuroscience research into the neurophysiology, developmental origins, familial associations, symptoms, neurocognition, and treatment of schizophrenia. This successful research program is characterized by frequent interaction and collaboration among different preclinical and clinical researchers within the MPRC and nearby SOM campus. Postdoctoral training offered under this T32 fellowship has a primary focus on either basic neuroscience or clinical investigations of schizophrenia. All trainees are educated on the translational perspective of the MPRC and provided mentors and didactic training in both clinical and neuroscience in schizophrenia. This resubmission for a competitive five-year renewal application proposes to fund 3 new trainee positions in each year, with each a fellowship lasting for 2 years. Although this is a very young T32 program, it is successful in terms of recruiting and training independent researchers. During the initial funding period, 10 trainees were enrolled. Four trainees completed the training program, 1 withdrew for personal reasons and 5 are currently in training. Of the 4 that completed, 3 have faculty appointments at the Assistant Professor level (at the University of Maryland Baltimore, University of Wales, Bangor, and the University of Osnabruck) and one is currently employed at the MPRC as research associate. Three of these graduates have received competitive funding. One current trainee will graduate from this program in July and has secured an assistant professorship position at the University of Maryland Baltimore. In addition, 2 of the 5 current trainees have received competitive NARSAD Young Investigator awards.

Public Health Relevance

Complex problems such as schizophrenia require a multidisciplinary clinical research workforce, accustomed to working in integrated teams. This proposal seeks to address the dwindling number of translational scientists studying severe mental illness by recruiting and mentoring clinical and preclinical post-docs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Institutional National Research Service Award (T32)
Project #
5T32MH067533-09
Application #
8465271
Study Section
Special Emphasis Panel (ZMH1-ERB-C (01))
Program Officer
Chavez, Mark
Project Start
2004-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$292,352
Indirect Cost
$21,103
Name
University of Maryland Baltimore
Department
Psychiatry
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Schiffman, Jason; Lawrence, Ryan E; Demro, Caroline et al. (2016) Attitudes towards cannabis use and genetic testing for schizophrenia. Early Interv Psychiatry 10:220-6
Koola, Maju Mathew; Raines, Jeffrey K; Hamilton, Robert G et al. (2016) Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia? Curr Psychiatr 15:52-57
Chiappelli, Joshua; Shi, Qiaoyun; Kodi, Priyadurga et al. (2016) Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia. Psychoneuroendocrinology 63:86-93
Bustillo, Juan R; Rediske, Nathan; Jones, Thomas et al. (2016) Reproducibility of phase rotation stimulated echo acquisition mode at 3T in schizophrenia: Emphasis on glutamine. Magn Reson Med 75:498-502
Koola, Maju Mathew (2016) Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine. Schizophr Res Cogn 4:4-9
Kochunov, Peter; Ganjgahi, Habib; Winkler, Anderson et al. (2016) Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia. Hum Brain Mapp 37:4673-4688
Du, Xiaoming; Kochunov, Peter; Summerfelt, Ann et al. (2016) The role of white matter microstructure in inhibitory deficits in patients with schizophrenia. Brain Stimul :
Rowland, L M; Krause, B W; Wijtenburg, S A et al. (2016) Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study. Mol Psychiatry 21:198-204
Kochunov, Peter; Thompson, Paul M; Winkler, Anderson et al. (2016) The common genetic influence over processing speed and white matter microstructure: Evidence from the Old Order Amish and Human Connectome Projects. Neuroimage 125:189-97
Korenic, Stephanie A; Nisonger, Sarah J; Krause, Benjamin W et al. (2016) Effectiveness of fast mapping to promote learning in schizophrenia. Schizophr Res Cogn 4:24-31

Showing the most recent 10 out of 69 publications